← FDA Drug Approvals (Drugs@FDA)
TOFACITINIB CITRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2023-09-25
Drug application
- FDA Application #
ANDA216878- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TOFACITINIB CITRATE
- Generic name
- Tofacitinib Citrate
- Active ingredients
- TOFACITINIB CITRATE
- Dosage form
- SOLUTION
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- HIKMA
- First approval
- 2023-09-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown